In the news
Biorce Receives $52.5M Series A to scale AI for Clinical Trials
Clinical Trials Arena news article about Biorce.

About Biorce
Biorce is an AI healthtech startup, building defensible AI solutions for clinical trial development. Its platform, Aika, is a continuous intelligent layer, from protocol decision to regulatory submission, enabling fewer amendments and a dramatic reduction of cost and time.
Media contact
Lynn Caroline Broeker
PR & Media collaborations
lynn.broeker@biorce.com







